Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Insignia™ Hip Stem Outcomes Study

NCT: NCT05144191 · ACTIVE_NOT_RECRUITING

NCT IDNCT05144191
StatusACTIVE_NOT_RECRUITING
Start Date2022-02-07
Completion2034-04-02
SponsorStryker Orthopaedics (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑